Cargando…
Oral melatonin in high-risk critically ill patients: quality of sedative effect
Autores principales: | Sabbatini, G, Mistraletti, G, Cerri, B, Miori, S, Galluccio, I, Tozzi, M, Villa, C, Umbrello, M, Fraschini, F, Iapichino, G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3363740/ http://dx.doi.org/10.1186/cc10929 |
Ejemplares similares
-
Endogenous melatonin in critically ill patients
por: Salice, VS, et al.
Publicado: (2013) -
Pharmacokinetics of orally administered melatonin in critically ill patients
por: Moroni, B, et al.
Publicado: (2010) -
Melatonin blood values and total antioxidant capacity in critically ill patients
por: D'Amato, LA, et al.
Publicado: (2014) -
Stressors in the ICU: different perceptions of patients, relatives and staff members
por: Umbrello, M, et al.
Publicado: (2012) -
Daily assay of procalcitonin, C-reactive protein and IL-6 roles in diagnosis and management of severe sepsis
por: Umbrello, M, et al.
Publicado: (2009)